Frontiers Outcome Measures in Clinical Trials of Patients With Myasthenia Gravis

Product Description

Resources for Researchers and Clinicians The Myasthenia Gravis Rare Disease Network

Frontiers Rituximab treatment in myasthenia gravis

Rozanolixizumab improves outcomes in severe myasthenia gravis

PDF] Myasthenia Gravis and Physical Exercise: A Novel Paradigm

Blog Archives - PlatformQ Health

Personality factors in patients with myasthenia gravis: A prospective study - Jordan - 2023 - Brain and Behavior - Wiley Online Library

BREAKING! COVID-19 News: Italian Researchers Report That SARS-CoV-2 Can Trigger Myasthenia Gravis, A Neuromuscular Disease - Thailand Medical News

Myasthenia Gravis: Case Study - Physiopedia

Rare Research Report: November 2023 Rare Diseases Clinical Research Network

Frontiers From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research

Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: a case series

Advances and challenges in the treatment of myasthenia gravis - Christiane Schneider-Gold, Nils Erik Gilhus, 2021

Stroke Care Costs and Cost-Effectiveness to Inform Health Policy